Anaptysbio (ANAB) Debt to Equity (2016 - 2018)

Anaptysbio has reported Debt to Equity for 3 years, with the latest figure at $0.0 in Q4 2018.

• For the quarter ending Q4 2018, Debt to Equity fell 94.77% year-over-year to $0.0; the trailing twelve-month figure through Dec 2018 stood at $0.0 (down 94.77% YoY), and the FY2018 full-year result was $0.0, down 94.77% from the prior year.
• Debt to Equity for Q4 2018 stood at $0.0, down from $0.0 in the prior quarter.
• The five-year high for Debt to Equity was $0.12 in Q1 2017, with the low at -$0.36 in Q4 2016.
• Historically, Debt to Equity has averaged $0.0 across 3 years, with a median of $0.02 in 2018.
• Annual changes were most pronounced in 2017 — Debt to Equity soared 106.8% — and 2018, when it tumbled 94.77%.
• Anaptysbio's Debt to Equity stood at -$0.36 in 2016, then soared by 106.8% to $0.02 in 2017, then plunged by 94.77% to $0.0 in 2018.
• The last three Debt to Equity figures came in at $0.0 (Q4 2018), $0.0 (Q3 2018), and $0.01 (Q2 2018), per Business Quant data.